Senzime AB (publ)
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more
Senzime AB (publ) (SNZZF) - Total Assets
Latest total assets as of June 2025: $435.22 Million USD
Based on the latest financial reports, Senzime AB (publ) (SNZZF) holds total assets worth $435.22 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Senzime AB (publ) - Total Assets Trend (2013–2024)
This chart illustrates how Senzime AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Senzime AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
Senzime AB (publ)'s total assets of $435.22 Million consist of 34.5% current assets and 65.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.8% |
| Accounts Receivable | $10.20 Million | 2.4% |
| Inventory | $27.97 Million | 6.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $136.76 Million | 32.2% |
| Goodwill | $114.66 Million | 27.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Senzime AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Senzime AB (publ)'s current assets represent 34.5% of total assets in 2024, an increase from 30.1% in 2013.
- Cash Position: Cash and equivalents constituted 23.8% of total assets in 2024, down from 26.2% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 3.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 32.2% of total assets.
Senzime AB (publ) Competitors by Total Assets
Key competitors of Senzime AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Senzime AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Senzime AB (publ) generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Senzime AB (publ) is currently not profitable relative to its asset base.
Senzime AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.22 | 4.53 | 8.51 |
| Quick Ratio | 5.17 | 3.61 | 8.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $154.47 Million | $ 98.51 Million | $ 71.76 Million |
Senzime AB (publ) - Advanced Valuation Insights
This section examines the relationship between Senzime AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.91 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -2.1% |
| Total Assets | $424.53 Million |
| Market Capitalization | $53.98 Million USD |
Valuation Analysis
Below Book Valuation: The market values Senzime AB (publ)'s assets below their book value (0.13 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Senzime AB (publ)'s assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Senzime AB (publ) (2013–2024)
The table below shows the annual total assets of Senzime AB (publ) from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $424.53 Million | -2.08% |
| 2023-12-31 | $433.54 Million | +34.36% |
| 2022-12-31 | $322.68 Million | +84.79% |
| 2021-12-31 | $174.62 Million | -32.55% |
| 2020-12-31 | $258.89 Million | +37.88% |
| 2019-12-31 | $187.76 Million | -4.77% |
| 2018-12-31 | $197.16 Million | +18.75% |
| 2017-12-31 | $166.03 Million | +6.22% |
| 2016-12-31 | $156.31 Million | +226.99% |
| 2015-12-31 | $47.80 Million | -14.69% |
| 2014-12-31 | $56.03 Million | +45.26% |
| 2013-12-31 | $38.57 Million | -- |